Audio Categories: News

FridayJul 27, 2018 8:30 am

CBDNewsAudio – Marijuana Company of America Inc. (MCOA) Poised to Profit from Increasingly Lenient CBD Laws

Related Editorial Recent growth in the market for cannabidiol (CBD) products has been strong and appears poised to continue. CBD is an active ingredient derived from industrial hemp that does not contain the psychoactive or “high” effect of marijuana. CBD is used in a wide range of products, from cosmetics to pet supplements. The recent acceptance of a CBD-based medicine by U.S. authorities creates potential for legal change that could make the sale of CBD easier. Attention in the mainstream press has created a measure of gravitas for CBD. Marijuana Company of America Inc. (OTC: MCOA) (MCOA Profile) has produced…

Continue Reading

FridayJul 20, 2018 8:30 am

CBDNewsAudio – Marijuana Company of America Inc. (MCOA) Offers All-natural Alternative to Synthetic Medicines

Related Editorial The opioid crisis in North America has drawn attention to the urgent need for alternative medicines, and hemp CBD products offer a viable plant-based option. An active ingredient in industrial hemp, Cannabidiol (CBD) can be extracted to be used in a number of different products such as topicals, tinctures, and capsules. The World Health Organization (WHO) has found CBD to be nonpsychoactive, nonaddictive, and to have a positive effect on patients’ health. Scientific studies have shown CBD to be effective in pain relief and, therefore, it may be a healthier alternative to addictive opioids. Marijuana Company of America…

Continue Reading

ThursdayJul 12, 2018 8:30 am

CBDNewsAudio – Marijuana Company of America Inc. (MCOA) Set to Benefit from Potential Cannabidiol Reclassification

Related Editorial Restrictions in the United States on cannabidiol (CBD), an active ingredient in cannabis, appear likely to loosen over the next few months, creating opportunities for CBD production and distribution companies. CBD is an active ingredient with medical benefits but no “high”, or pyshcoactive effects. The Food and Drug Administration (FDA) has approved a CBD-based medicine for the first time. Companies are cultivating hemp to develop high yielding CBD plants. Marijuana Company of America, Inc. (OTC: MCOA) (MCOA Profile) is cultivating industrial hemp for CBD  propagation at sites in the United States and Canada while continuting to develop and…

Continue Reading

FridayJun 29, 2018 8:30 am

CBDNewsAudio – Marijuana Company of America Inc. (MCOA) Vertically Integrates Hemp Production and Sales

Related Editorial The United States House passed the 2018 Farm Bill, which will redefine subsidies to farmers, nutritional welfare recipients, conservationists and others. Tucked into this bill of more than 1,000 pages is hemp legalization legislation supported by Senate Majority Leader Mitch McConnell. Demand – and thus farming revenue – for tobacco is waning, and McConnell says hemp farming could help bolster farming communities in his home state of Kentucky and across the country. Currently listed as a controlled substance under federal law, the new bill will declassify hemp as a schedule 1 drug and label it as a viable…

Continue Reading

FridayJun 22, 2018 8:30 am

CBDNewsAudio – Marijuana Company of America Inc. (MCOA) Shuns Synthetics, Offering Only Pure Hemp-based Products

Related Editorial Dating back thousands of years, people have found ways to treat pain and other ailments with cannabidiol (CBD) oil which is harvested from the hemp plant. However, the natural healing properties of CBD are being jeopardized by the advent of man-made synthetic CBDs. These chemical analogs are dangerous imitations of plant-derived product, binding to human endocannabinoid receptors at astronomically larger quantities than natural cannabinoids. These designer drugs prompted the U.S. Centers for Disease Control and Prevention to issue a national health alert warning about synthetic cannabinoids. Shunning synthetics, Marijuana Company of America, Inc. (OTC: MCOA) (MCOA Profile) provides…

Continue Reading

FridayJun 15, 2018 8:30 am

CBDNewsAudio – Marijuana Company of America Inc. (MCOA) Contributes to Industry Growth Through Hemp Cultivation Projects

Related Editorial Recent U.S. government interest in ensuring industrial hemp supply signals a period of growth for the cannabinoid industry. Marijuana Company of America Inc. (OTC: MCOA) (MCOA Profile) is contributing to this growth through new hemp cultivation projects in both Canada and the U.S., to support its hempSMART subsidiary. Cronos Group Inc. (TSX: CRON) (NASDAQ: CRON) is benefiting from a cross-border venture that gives it access to new scientific advances and has seen its shares reach top exchanges. Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) has secured government licensing needed to become one of Canada’s leading retailers, while acquiring…

Continue Reading

MondayJun 11, 2018 8:30 am

CBDNewsAudio – Marijuana Company of America Inc. (MCOA) Takes Advantage of Promising Opportunities in Wide-ranging Cannabis Sector

Related Editorial The cannabis industry is about more than medicine and recreational drugs. Whether selling hemp-derived textile and construction products or providing resources to support cannabis growers, companies are now accessing the market in a variety of ways. Marijuana Company of America Inc. (OTC: MCOA) (MCOA Profile) is developing hemp-based wellness products and cultivating industrial hemp on a large scale in Canada and the United States. Scotts Miracle-Gro Company (NYSE: SMG) is selling hydroponic equipment to legal cannabis growers and has recently made a significant acquisition in this area. Cronos Group, Inc. (TSX: CRON) (NASDAQ: CRON) has used its success…

Continue Reading

MondayJun 04, 2018 8:30 am

CBDNewsAudio – Marijuana Company of America Inc. (MCOA) Capitalizes on the Rising Acceptance of CBD

Related Editorial In a fragile economic world, industries with significant growth forecast are certain to catch the eye of savvy investors looking for just the right place to be. Recent reports indicate that the cannabidiol (CBD) market is estimated to grow by 700 percent by 2020, and a report by market intelligence firm Hemp Business Journal projects that the CBD market will grow to $2.1 billion by 2020 (http://cnw.fm/7iczS), an astronomical jump in value compared to last year’s CBD market of $202 million. This news bodes well for hemp-focused companies such as Marijuana Company of America (OTC: MCOA) (MCOA Profile),…

Continue Reading

TuesdayMay 29, 2018 8:30 am

CBDNewsAudio – Marijuana Company of America Inc. (MCOA) Well-positioned in Emergent Industrial Hemp-based CBD Market

Related Editorial With the announcement in April of the Industrial Hemp Farming Act of 2018, the industry could be looking at a federal redefinition of hemp. Industrial hemp is a great source for CBD (cannabidiol), a non-psychoactive cannabinoid with numerous medical applications ranging (http://cnw.fm/7tqIy). U.S. market projections for hemp range from $1.9 to $2.1 billion within the next two years and could hit $3 billion by 2021, according to one industry analyst (http://cnw.fm/MLA5w). This is great news for well-positioned sector players such as Marijuana Company of America (OTC: MCOA) (MCOA Profile), which recently executed a sizeable hemp-cultivation JV agreement. Other…

Continue Reading

FridayMay 25, 2018 8:30 am

CBDNewsAudio – Global Payout, Inc. (GOHE) Secures Spot in Growing Cannabis Industry

Related Editorial The legalization of cannabis for recreational use in Canada appears to be certain by the end of summer. The legislation to begin that process was passed by the government in late 2017 and passed a second reading in the country’s Senate in March 2018; the final vote is scheduled for June of this year, and the passage appears all but certain. Approval of the law — along with the fact that recreational cannabis is already legal in nine U.S. states — will spark an industry that forecasts indicate may reach as high as $12B in North America (http://cnw.fm/Fem3T),…

Continue Reading